Immune modulation with IL-2 and IL-12.
Boonprakong
L
L
University of Washington, School of Medicine, AIDS Clinical Trials Unit, Seattle, WA.
D019380:Anti-HIV Agents / Q000627:therapeutic use; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D016207:Cytokines / Q000276:immunology / Q000627:therapeutic use; D016049:Didanosine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D018664:Interleukin-12 / Q000276:immunology* / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000276:immunology* / Q000627:therapeutic use*; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D016207:Cytokines; D007376:Interleukin-2; D018664:Interleukin-12; D015215:Zidovudine; D016049:Didanosine